nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.365	1	CrCtD
Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.163	1	CbGaD
Bupranolol—Clenbuterol—Salbutamol—chronic obstructive pulmonary disease	0.0543	0.222	CrCrCtD
Bupranolol—Pirbuterol—Salbutamol—chronic obstructive pulmonary disease	0.0469	0.192	CrCrCtD
Bupranolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0446	0.2	CbGbCtD
Bupranolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.044	0.197	CbGbCtD
Bupranolol—Nadolol—Salbutamol—chronic obstructive pulmonary disease	0.0373	0.153	CrCrCtD
Bupranolol—Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.0373	0.153	CrCrCtD
Bupranolol—Carteolol—Salbutamol—chronic obstructive pulmonary disease	0.0373	0.153	CrCrCtD
Bupranolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0338	0.152	CbGbCtD
Bupranolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0338	0.152	CbGbCtD
Bupranolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0333	0.149	CbGbCtD
Bupranolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0333	0.149	CbGbCtD
Bupranolol—Terbutaline—Salbutamol—chronic obstructive pulmonary disease	0.0312	0.128	CrCrCtD
Bupranolol—ADRB3—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.000311	0.116	CbGpPWpGaD
Bupranolol—Gemfibrozil—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.0955	CrCbGaD
Bupranolol—Pirbuterol—ADRB2—chronic obstructive pulmonary disease	0.000192	0.0931	CrCbGaD
Bupranolol—ADRB1—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.000185	0.0686	CbGpPWpGaD
Bupranolol—Levobunolol—ADRB2—chronic obstructive pulmonary disease	0.000172	0.083	CrCbGaD
Bupranolol—Timolol—ADRB2—chronic obstructive pulmonary disease	0.000164	0.0792	CrCbGaD
Bupranolol—Terbutaline—ADRB2—chronic obstructive pulmonary disease	0.000157	0.0759	CrCbGaD
Bupranolol—Carteolol—ADRB2—chronic obstructive pulmonary disease	0.000146	0.0706	CrCbGaD
Bupranolol—Clenbuterol—TNF—chronic obstructive pulmonary disease	0.000142	0.0685	CrCbGaD
Bupranolol—Nadolol—ADRB2—chronic obstructive pulmonary disease	0.00013	0.0629	CrCbGaD
Bupranolol—Clenbuterol—ADRB2—chronic obstructive pulmonary disease	0.000125	0.0607	CrCbGaD
Bupranolol—Bopindolol—ADRB2—chronic obstructive pulmonary disease	0.000119	0.0575	CrCbGaD
Bupranolol—Salbutamol—ADRB2—chronic obstructive pulmonary disease	0.000117	0.0564	CrCbGaD
Bupranolol—Penbutolol—ADRB2—chronic obstructive pulmonary disease	0.000113	0.0549	CrCbGaD
Bupranolol—ADRB3—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00011	0.0408	CbGpPWpGaD
Bupranolol—Clenbuterol—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.052	CrCbGaD
Bupranolol—Clenbuterol—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.0502	CrCbGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	9.25e-05	0.0343	CbGpPWpGaD
Bupranolol—ADRB3—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	8.6e-05	0.0319	CbGpPWpGaD
Bupranolol—ADRB1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	8.35e-05	0.031	CbGpPWpGaD
Bupranolol—Pindolol—ADRB2—chronic obstructive pulmonary disease	8.18e-05	0.0396	CrCbGaD
Bupranolol—ADRB3—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	7.55e-05	0.028	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	7.23e-05	0.0268	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	6.53e-05	0.0242	CbGpPWpGaD
Bupranolol—ADRB1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	6.47e-05	0.024	CbGpPWpGaD
Bupranolol—ADRB1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	6.06e-05	0.0225	CbGpPWpGaD
Bupranolol—ADRB1—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	5.84e-05	0.0217	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	5.49e-05	0.0204	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	5.11e-05	0.019	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	4.99e-05	0.0185	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	4.52e-05	0.0168	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	4.48e-05	0.0166	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	4.38e-05	0.0163	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	4.29e-05	0.0159	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	4.2e-05	0.0156	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	3.82e-05	0.0142	CbGpPWpGaD
Bupranolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	3.56e-05	0.0132	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	3.39e-05	0.0126	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	3.29e-05	0.0122	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	2.9e-05	0.0108	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	2.26e-05	0.00841	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	2.22e-05	0.00824	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	2.21e-05	0.0082	CbGpPWpGaD
Bupranolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	2.15e-05	0.00799	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	2.12e-05	0.00788	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	2.01e-05	0.00746	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	1.97e-05	0.0073	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	1.96e-05	0.00726	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.82e-05	0.00675	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.81e-05	0.00672	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	1.72e-05	0.00639	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	1.68e-05	0.00625	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.66e-05	0.00616	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.63e-05	0.00604	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.55e-05	0.00575	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.42e-05	0.00528	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.41e-05	0.00522	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.39e-05	0.00514	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.31e-05	0.00487	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.28e-05	0.00476	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	1.26e-05	0.00468	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.25e-05	0.00463	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.24e-05	0.0046	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.13e-05	0.00421	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.00407	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.08e-05	0.00402	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.08e-05	0.00401	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.07e-05	0.00399	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.05e-05	0.0039	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.85e-06	0.00366	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.65e-06	0.00358	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.64e-06	0.00358	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.44e-06	0.0035	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.19e-06	0.00341	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.99e-06	0.00334	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.79e-06	0.00326	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.44e-06	0.00313	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.35e-06	0.0031	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.31e-06	0.00308	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.26e-06	0.00307	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.22e-06	0.00305	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.16e-06	0.00303	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.83e-06	0.00291	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.41e-06	0.00275	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.35e-06	0.00273	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.25e-06	0.00269	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.19e-06	0.00267	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.11e-06	0.00264	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7e-06	0.0026	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.73e-06	0.0025	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.7e-06	0.00249	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.69e-06	0.00248	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.58e-06	0.00244	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.51e-06	0.00241	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.43e-06	0.00239	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.36e-06	0.00236	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.35e-06	0.00236	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.29e-06	0.00233	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.12e-06	0.00227	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.56e-06	0.00206	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.22e-06	0.00194	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.1e-06	0.00189	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.93e-06	0.00183	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.9e-06	0.00182	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.82e-06	0.00179	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.65e-06	0.00173	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.55e-06	0.00169	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.22e-06	0.00157	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.2e-06	0.00156	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.15e-06	0.00154	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.06e-06	0.00151	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.97e-06	0.00148	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.97e-06	0.00147	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.89e-06	0.00144	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.88e-06	0.00144	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.78e-06	0.0014	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.77e-06	0.0014	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.75e-06	0.00139	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.69e-06	0.00137	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.63e-06	0.00135	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.55e-06	0.00132	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.43e-06	0.00127	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.41e-06	0.00127	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.3e-06	0.00122	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.28e-06	0.00122	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.23e-06	0.0012	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.05e-06	0.00113	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.91e-06	0.00108	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.84e-06	0.00106	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.7e-06	0.001	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.64e-06	0.000981	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.51e-06	0.000932	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.49e-06	0.000925	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.4e-06	0.000889	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.29e-06	0.000849	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.24e-06	0.000833	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.23e-06	0.000827	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.2e-06	0.000815	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.18e-06	0.000809	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.04e-06	0.000757	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.03e-06	0.000753	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.02e-06	0.000752	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.99e-06	0.00074	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.98e-06	0.000735	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.95e-06	0.000723	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.93e-06	0.000716	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.91e-06	0.000708	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.83e-06	0.000681	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.81e-06	0.000673	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.77e-06	0.000658	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.65e-06	0.000612	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.51e-06	0.000561	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.49e-06	0.000553	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.48e-06	0.00055	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.46e-06	0.000541	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.42e-06	0.000528	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.39e-06	0.000516	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.36e-06	0.000504	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.33e-06	0.000493	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.24e-06	0.000462	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.2e-06	0.000447	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.18e-06	0.000437	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.14e-06	0.000425	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.14e-06	0.000423	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.12e-06	0.000416	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.09e-06	0.000404	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.07e-06	0.000395	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.78e-07	0.000363	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.57e-07	0.000355	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.98e-07	0.000333	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.8e-07	0.000327	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.78e-07	0.000326	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.61e-07	0.00032	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.39e-07	0.000274	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.23e-07	0.000268	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.76e-07	0.000251	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.62e-07	0.000246	CbGpPWpGaD
